🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH biomarker panel — looking for input Page 5

MASH biomarker panel — looking for input

tammy_FL Wed, Apr 16, 2025 at 3:46 PM 31 replies 2,203 viewsPage 5 of 7
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Apr 30, 2025 at 9:39 PM#21
PharmacoVig_BOS said:
Keep the original post as written when you update it, and add the correction underneath.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

34 7DebRD_ATL, KristenIndy, MarkLI_maint and 31 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
May 6, 2025 at 6:58 AM#22
PharmacoVig_BOS said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

35 8mike_nyc, VendorMark, COA_Karl and 32 others
Reply Quote Save Share Report
emma_london
Member
312
1,456
Oct 2024
London, UK
May 11, 2025 at 4:20 PM#23
PharmacoVig_BOS said:
Keep the original post as written when you update it, and add the correction underneath.

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

Last edited: May 11, 2025 at 10:20 PM
36 9TomFromTexas, mike.trainer_LA, sarah_nash92 and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
May 17, 2025 at 1:46 AM#24

From the other side of the consultation, briefly. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: May 17, 2025 at 7:46 AM
37 10mike.trainer_LA, sarah_nash92, FitDadDave and 34 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
May 22, 2025 at 11:15 AM#25
Dr.KarenChen said:
If two explanations both fit, the useful question is which one predicts something the other does not.

This matches mine closely enough to be worth saying so out loud.

38 11SaraMom3, Dr.MetabolicMD, RetaRick_CA and 35 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register